Study of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Reduced-Dose Cyclosporine Microemulsion (CsA-ME) Compared to EC-MPS Plus Standard Dose CsA-ME in Eldery de Novo Renal Transplant Recipients Treated With Basiliximab and Short-Term Steroids
This study is ongoing, but not recruiting participants.
Study NCT00239031
Information provided by Novartis
First Received: October 12, 2005
Last Updated: July 21, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study: